These newer treatments , including Rybelsus, belong to a group of drugs called GLP-1 agents. Originally intended for managing type 2 diabetes , they operate by helping the organism to produce sufficient insulin and curbing excessive glucose levels. Additionally , their capacity to encourage weigh